This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


PL Developments Expands Ops

WESTBURY, N.Y.—PL Developments acquired the assets of PAL Laboratories, a contract manufacturing operation in Miami; the facility is capable of manufacturing pharmaceutical, OTC and dietary supplements tablets, caplets and two-piece capsules. PL Developments is forming a new subsidiary, Avema Pharma Solutions, from the Miami operation, with a focus on developing and manufacturing new products into those markets, while PL Developments will focus on the OTC, private label market.

Mitchell Singer, president and CEO, PL Developments, said: “This acquisition is exciting for everyone at PL Developments. We believe that the synergies between the two companies are substantial. This FDA inspected facility will allow us to develop and manufacture exciting new Rx/OTC products that we will be able to deliver to our retail partners such as Wal-Mart, Costco, CVS and Walgreen’s.”

comments powered by Disqus